Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

Regeneron is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction.

Related Posts

The biggest questions facing Big Tech ahead of earnings

TechnoHulk Apr 21, 2025  0

Alibaba jumps 4% in premarket after it completes three-...

TechnoHulk Aug 30, 2024  0

Apple announces iPhone event for Sept. 9

TechnoHulk Aug 26, 2024  0

Comments

Name

Email

Comment

Post Comment